Dermatophagoides farinae clinical trials
How each study uses Dermatophagoides farinae is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Dermatophagoides farinae studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 13 Mar 1924 · N/A · BLA 103870 (FDA, Purple Book)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 2
Abbott (1) · Gachon University Gil Medical Center (1) · RAPHAS (1) · University of North Carolina, Chapel Hill (1) · Roxall Medizin (1)
Studies
Open first, then newest update. How each study uses Dermatophagoides farinae is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis PatientsEnrolling by invitationPhase 1RAPHASNCT05525650Written as House Dust Mite Extract, Dermatophagoides Farinae
- Screening Inhaled Allergen Challenge for Dermatophagoides FarinaeTerminatedEarly Phase 1University of North Carolina, Chapel HillNCT03049111Written as Der f
- A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic AsthmaCompletedPhase 3AbbottNCT02596321Written as Mitizax
- Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual ImmunotherapyStatus unknownPhase 3Roxall MedizinNCT01014325Written as Allergen extract
- Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic RhinitisCompletedPhase 1Gachon University Gil Medical CenterNCT02301884Written as Allergen extract
Given beside what is tested · 2 — Dermatophagoides farinae is usual care or a partner of the new treatment
- Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway InflammationWithdrawnPhase 1/2University of North Carolina, Chapel HillNCT03513458Written as Dermatophagoides Farinae
- Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway InflammationWithdrawnPhase 1/2University of North Carolina, Chapel HillNCT03513471Written as Dermatophagoides Farinae
Codes
What other systems call Dermatophagoides farinae · ClinicalTrials.gg INT017605
- Wikidata Q2916791Dermatophagoides farinaeOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q2916791 | Dermatophagoides farinae | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.